|
Core Support for Cancer Center
|
2P30CA013330-40
|
$3,589,611
|
$143,584
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-40S1
|
$75,000
|
$3,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5R00CA139009-04
|
$234,060
|
$234,060
|
Ito, Keisuke
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The role of c-Maf in Stem cells in Leukemia
|
5F31CA162770-03
|
$42,232
|
$21,116
|
Okoye, Ujunwa
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
3U10CA014958-38S1
|
$144,167
|
$11,533
|
Sparano, Joseph
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia
|
1R01CA166429-01A1
|
$384,342
|
$384,342
|
Steidl, Ulrich
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours Community Clinical Oncology Program
|
1U10CA176879-01
|
$558,366
|
$167,510
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Novel Therapeutic Strategy for Refractory and Relapse Childhood Acute Leukemia
|
1R43CA171344-01A1
|
$240,322
|
$240,322
|
Haslanger, Martin
|
APEX THERAPEUTICS, INC.
|
|
Charge sensitive optical detection for high throughput study of small molecules
|
5R21CA173205-02
|
$218,250
|
$218,250
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
BCR-ABL1 RT-qPCR Test for improved monitoring of CML
|
N43CA130019-000
|
$241,044
|
$241,044
|
BROWN, PH.D, JUSTIN
|
ASURAGEN, INC.
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
$48,617
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
DISCOVERY OF SMALL MOLECULAR ACTIVATORS OF NR4A ORPHAN NUCLEAR RECEPTORS
|
5R01CA160747-02
|
$305,253
|
$305,253
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk
|
5K23CA158148-02
|
$168,578
|
$168,578
|
Gramatges, Maria
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-07
|
$2,150,500
|
$795,685
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
1R01CA164024-01A1
|
$385,859
|
$385,859
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
|
1R01CA163849-01A1
|
$477,421
|
$477,421
|
Justice, Monica
|
BAYLOR COLLEGE OF MEDICINE
|
|
Development of a Novel Mouse Model to Evaluate HTLV Tax Transformation
|
1R21CA175404-01
|
$200,308
|
$200,308
|
Marriott, Susan
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$5,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$3,029
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
$216,497
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Eastern Cooperative Oncology Group
|
3U10CA080775-14S1
|
$43,980
|
$3,518
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-04
|
$329,206
|
$82,302
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting PML for leukemia therapy.
|
5R01CA142874-04
|
$425,460
|
$425,460
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Lig4R278H contribution to HSC and IgH class switching defects and malignancies
|
1R01CA161151-01A1
|
$361,048
|
$180,524
|
Yan, Catherine
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Rapid Testing of Drug Resistant BCR-ABL(+) Leukemia Cells
|
2R44CA153614-02
|
$613,119
|
$613,119
|
Rieder, Ronald
|
BIOSENSE TECHNOLOGIES, INC.
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
5R00CA134743-04
|
$245,188
|
$196,150
|
Feng, Hui
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Oncogenic Notch Signaling
|
3P01CA119070-06A1S1
|
$58,609
|
$35,751
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Oncogenic Notch Signaling
|
3P01CA119070-07S1
|
$55,093
|
$33,607
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Oncogenic Notch Signaling
|
5P01CA119070-07
|
$956,051
|
$583,191
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-28S1
|
$362,418
|
$7,248
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-32
|
$9,816,255
|
$294,488
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-29
|
$2,684,982
|
$53,700
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B Human Specimen Repositories
|
5U24CA114725-09
|
$1,086,261
|
$543,131
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Tribbles-COP1 Complex in Leukemia
|
1K08CA166227-01A1
|
$178,200
|
$178,200
|
ULJON, SACHA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mapping the transcriptional regulatory circuits of human hematopoiesis
|
5F32CA168253-02
|
$49,214
|
$49,214
|
Cheng, Christine
|
BROAD INSTITUTE, INC.
|
|
Broad Institute Center for Cancer Systems Biology
|
3U54CA112962-09S1
|
$68,730
|
$17,183
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
Broad Institute Center for Cancer Systems Biology
|
5U54CA112962-09
|
$2,004,265
|
$501,066
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-30
|
$828,213
|
$8,282
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
Eastern Cooperative Oncology Group Studies
|
3U10CA014548-38S1
|
$334,918
|
$26,793
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Bcl-2 function on the endoplasmic reticulum
|
5R01CA085804-14
|
$267,381
|
$106,952
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
3U01CA062502-19S1
|
$841,154
|
$50,469
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-23
|
$4,740,480
|
$142,214
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-23S2
|
$37,026
|
$1,111
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cell signaling as a leukemia biomarker
|
5R21CA158659-02
|
$160,494
|
$160,494
|
JACOBBERGER, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Next-generation mouse gene-targeting technology to model tumorigenesis
|
1R21CA181859-01
|
$241,316
|
$79,634
|
Wang, Zhenghe
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Pax5:Hematopoietic Transcription Factor Involved in ALL
|
5R01CA026038-34
|
$343,368
|
$343,368
|
Koeffler, Harold
|
CEDARS-SINAI MEDICAL CENTER
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-11
|
$24,894,951
|
$14,688,021
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Genetic Predictors of AML Treatment Response
|
5R01CA133881-04
|
$522,609
|
$522,609
|
Aplenc, Richard
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Toxicity Monitoring on Phase III Trials with Administrative Data
|
5R01CA165277-02
|
$461,557
|
$461,557
|
Aplenc, Richard
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
MLL in Hematopoiesis and Leukemia in the Zebrafish Model
|
5R01CA153348-04
|
$375,268
|
$375,268
|
Felix, Carolyn
|
CHILDREN'S HOSP OF PHILADELPHIA
|
Total relevant funding to Leukemia for this search: $234,861,010
|